Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

28.42
Delayed Data
As of May 27
 +1.48 / +5.49%
Today’s Change
23.55
Today|||52-Week Range
263.81
-72.04%
Year-to-Date
3 Stocks You Can Love at New Highs
May 27 / Zacks.com - Paid Partner Content
Analysts Differ On Impact Of Valeant's Rejected Takeover Bid
May 27 / TheStreet.com - Paid Partner Content
Another Month, Another 3 Reasons to Avoid Valeant Pharmaceuticals
May 27 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Surges on Rejected Takeda, TPG Bid Speculation
May 27 / TheStreet.com - Paid Partner Content
Trending Tickers: ULTA, LC, PANW, VRX, FEIC
May 27 / TheStreet.com - Paid Partner Content
First-Quarter GDP Revised Upward; Futures Indicate Higher Opening
May 27 / TheStreet.com - Paid Partner Content
Wally Weitz Drops Falling Drug Stock Endo but Sees 'Upside Potential'
May 27 / GuruFocus News - Paid Partner Content
Frontrunning: May 27
May 27 / Investing Channel - Paid Partner Content
Pershing Square's, and Ackmans, Less Talked About Positions
May 27 / GuruFocus News - Paid Partner Content
All Eyes On Yellen: Global Markets Flat On Dreadful Volumes, Oil Slides
May 27 / Investing Channel - Paid Partner Content

Today’s Trading

Previous close26.94
Today’s open28.19
Day’s range27.84 - 29.41
Volume34,206,438
Average volume (3 months)26,562,237
Market cap$8.9B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-16.58%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-0.68-0.45%
IDXXIDEXX Laboratories I...+0.33+0.37%
MDVNMedivation Inc+0.32+0.53%
RDYDr.Reddy's Laborator...+0.63+1.38%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJune 10, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Executive VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs